Long-Term Outcomes of BMMSC Compared with BMMNC for Treatment of Critical Limb Ischemia and Foot Ulcer in Patients with Diabetes

Long-Term Outcomes of BMMSC Compared with BMMNC for Treatment of Critical Limb Ischemia and Foot Ulcer in Patients with Diabetes

We first compared long-term clinical outcomes in treating critical limb ischemia (CLI) and foot ulcer in patients with diabetes between autologous bone marrow mesenchymal stem cell (BMMSC) and bone-marrow-derived mononuclear cell (BMMNC) transplants. Forty-one patients were enrolled and followed up...

Full description

Bibliographic Details
Main Authors: Debin Lu, Youzhao Jiang, Wuquan Deng, Yan Zhang, Ziwen Liang, Qinan Wu, Xiaoyan Jiang, Ling Zhang, Fang Gao, Ying Cao, Bing Chen, Yaoming Xue
Format: Article
Language:English
Published: SAGE Publishing 2019-05-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/0963689719835177

Similar Items

Similar Items